Heterogeneous burden of lung disease in smokers with borderline airflow obstruction.

TitleHeterogeneous burden of lung disease in smokers with borderline airflow obstruction.
Publication TypePublication
Year2018
AuthorsPirozzi CS, Gu T, Quibrera PM, Carretta EE, Han MK, Murray S, Cooper CB, Tashkin DP, Kleerup EC, Barjaktarevic I, Hoffman EA, Martinez CH, Christenson SA, Hansel NN, R Barr G, Bleecker ER, Ortega VE, Martinez FJ, Kanner RE, Paine R
Corporate AuthorsNHLBI SubPopulations and InteRmediate Outcome Measures In COPD Study(SPIROMICS)
JournalRespir Res
Volume19
Issue1
Pagination223
Date Published2018 Nov 20
ISSN1465-993X
KeywordsAged, Cohort Studies, Cost of Illness, Female, Forced Expiratory Volume, Humans, Lung Diseases, Male, Middle Aged, Prospective Studies, Pulmonary Disease, Chronic Obstructive, Pulmonary Emphysema, Smokers, Spirometry, Vital Capacity
Abstract

BACKGROUND: The identification of smoking-related lung disease in current and former smokers with normal FEV is complex, leading to debate regarding using a ratio of forced expiratory volume in 1 s to forced vital capacity (FEV/FVC) of less than 0.70 versus the predicted lower limit of normal (LLN) for diagnosis of airflow obstruction. We hypothesized that the discordant group of ever-smokers with FEV/FVC between the LLN and 0.70 is heterogeneous, and aimed to characterize the burden of smoking-related lung disease in this group.METHODS: We compared spirometry, chest CT characteristics, and symptoms between 161 ever-smokers in the discordant group and 940 ever-smokers and 190 never-smokers with normal FEV and FEV/FVC > 0.70 in the SPIROMICS cohort. We also estimated sensitivity and specificity for diagnosing objective radiographic evidence of chronic obstructive pulmonary disease (COPD) using different FEV/FVC criteria thresholds.RESULTS: The discordant group had more CT defined emphysema and non-emphysematous gas trapping, lower post-bronchodilator FEV and FEF, and higher respiratory medication use compared with the other two groups. Within the discordant group, 44% had radiographic CT evidence of either emphysema or non-emphysematous gas trapping; an FEV/FVC threshold of 0.70 has greater sensitivity but lower specificity compared with LLN for identifying individuals with CT abnormality.CONCLUSIONS: Ever-smokers with normal FEV and FEV/FVC <  0.70 but > LLN are a heterogeneous group that includes significant numbers of individuals with and without radiographic evidence of smoking-related lung disease. These findings emphasize the limitations of diagnosing COPD based on spirometric criteria alone.

DOI10.1186/s12931-018-0911-z
Alternate JournalRespir Res
PubMed ID30454050
PubMed Central IDPMC6245799
Grant ListHHSN268200900019C / HL / NHLBI NIH HHS / United States
U01 HL128952 / HL / NHLBI NIH HHS / United States
P30 ES005605 / ES / NIEHS NIH HHS / United States
P30 ES006694 / ES / NIEHS NIH HHS / United States
R01 HL122438 / NH / NIH HHS / United States
HHSN268200900015C / HL / NHLBI NIH HHS / United States
U01 HL137880 / HL / NHLBI NIH HHS / United States
R01 HL122438 / HL / NHLBI NIH HHS / United States
HHSN268200900013C / HL / NHLBI NIH HHS / United States
K23 HL130627 / HL / NHLBI NIH HHS / United States
HHSN268200900014C / HL / NHLBI NIH HHS / United States
K24 HL138188 / HL / NHLBI NIH HHS / United States
K24 HL137013 / HL / NHLBI NIH HHS / United States
HHSN268200900013C, HHSN268200900014C, HHSN268200900015C, HHSN268200900016C, HHSN268200900017C, HHSN268200900018C HHSN268200900019C, HHSN268200900020C / HL / NHLBI NIH HHS / United States
K24 HL138188 / NH / NIH HHS / United States
HHSN268200900016C / HL / NHLBI NIH HHS / United States
HHSN268200900017C / HL / NHLBI NIH HHS / United States
HHSN268200900020C / HL / NHLBI NIH HHS / United States
MS#: 
MS041
Manuscript Full Title: 
Heterogeneous burden of lung disease in smokers with borderline airflow obstruction.
Manuscript Lead/Corresponding Author Affiliation: 
Clinical Center: Utah (University of Utah)
ECI: 
Manuscript Status: 
Published and Public